Latest filing published 30 Oct 2026 for Regeneron Pharmaceuticals, INC., €878k.
Insider track record
No signal scores available.
McCourt Marion: trading record in brief
McCourt Marion discloses dealings in Regeneron Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 3 September 2026 to 30 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 30 October 2026: a transaction of €878k, in Regeneron Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to McCourt Marion
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,132 shares@ US$869.43CommonSEC144:0001969223-26-001108
- 1,131 shares@ US$857.000.0011% mcap1.6% of flowCommonSEC144:0001969223-26-000991
2 of 2 declarations
